Respiratory Medicine
Volume 104, Issue 5 , Pages 754-757 , May 2010

Point-of-care Arkansas method for measuring adherence to treatment with isoniazid

  • Renata L. Guerra

      Affiliations

    • Institute of Thoracic Diseases, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    • Corresponding Author InformationCorresponding author. Tuberculosis Clinical Research Laboratory, Institute of Thoracic Diseases, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco, No. 255, 6° andar, Cidade Universitária, Rio de Janeiro, RJ CEP: 21941-913, Brazil. Tel.: +55 21 2562 2432; fax: +55 21 2562 2853.
    • ,
  • Marcus B. Conde

      Affiliations

    • Institute of Thoracic Diseases, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    • ,
  • Anne Efron

      Affiliations

    • Johns Hopkins University School of Medicine, Baltimore, MD, USA
    • ,
  • Carla Loredo

      Affiliations

    • Institute of Thoracic Diseases, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    • ,
  • Gisele Bastos

      Affiliations

    • Institute of Thoracic Diseases, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    • ,
  • Richard E. Chaisson

      Affiliations

    • Johns Hopkins University School of Medicine, Baltimore, MD, USA
    • ,
  • Jonathan E. Golub

      Affiliations

    • Johns Hopkins University School of Medicine, Baltimore, MD, USA

Received 2 September 2009 ,Accepted 1 February 2010.

References 

  1. Churchyard G, Fielding K, Charalambous S, et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?. AIDS. 2003;17(14):2063–2070
  2. American Thoracic Society . Targeted tuberculosis testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:5221–5247
  3. Schraufnagel DE, Stoner R, Whiting E, Snukst-Torbeck G, Werhane MJ. Testing for isoniazid. An evaluation of the Arkansas method. Chest. 1990;98(2):314–316
  4. Elizaga J, Friedland JS. Monitoring compliance with antituberculous treatment by detection of isoniazid in urine. Lancet. 1997;350:1225–1226
  5. Perry S, Hovell MF, Blumberg E, et al. Urine testing to monitor adherence to TB preventive therapy. J Clin Epidemiol. 2002;55:235–238
  6. Eidlitz-Markus T, Zeharia A, Baum G, Mimouni M, Amir J. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Chest. 2003;123:736–739
  7. Whitfield R, Cope GF. Point-of-care test to monitor adherence to anti-tuberculosis treatment. Ann Clin Biochem. 2004;41:411–413
  8. Moulton LH, Golub JE, Durovni B, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials. 2007;4(2):190–199
  9. White MC, Tulsky JP, Reilly P, McIntosh HW, Hoynes TM, Goldenson J. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis. 1998;2:506–512
  10. Ellard GA, Jenner PJ, Downs PA. An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs. Br J Clin Pharmacol. 1980;10:369–381
  11. Hanifa Y, Mngadi K, Lewis J, Fielding K, Churchyard G, Grant AD. Evaluation of the Arkansas method of urine testing for isoniazid in South Africa. Int J Tuberc Lung Dis. 2007;11:1232–1236

PII: S0954-6111(10)00050-8

doi: 10.1016/j.rmed.2010.02.001

Respiratory Medicine
Volume 104, Issue 5 , Pages 754-757 , May 2010

Article Tools